Resultados de la búsqueda 261-270 of 12315 for Monocytosis

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Chemotherapy drugs, such as capecitabine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to investigate whether VNS therapy leads to any changes in the cognitive functions of individuals who have survived a stroke. A ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The Mayo Clinic Upper Digestive Disease Survey has been created in order to have a consistent evaluation tools for patients undergoing ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  5. Dermatología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop a registry to collect long-term data on patients with pediatric cutaneous mastocytosis, and develop better knowledge ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...